SRRK — Scholar Rock Holding Share News
0.000.00%
Last trade - 00:00Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Under Armour, GE Vernova, Walmart
U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital
Scholar Rock surges after FDA to reinspect Catalent manufacturing site
Drug developer Scholar Rock's Q3 net loss widens
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv
U.S. STOCKS ON THE MOVE-Broadcom, JPMorgan, Enpro
Scholar Rock tumbles after FDA action on manufacturing site
Brief: Scholar Rock Says FDA Determined Catalent Indiana Inspection Classification As OAI
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation
Scholar Rock climbs after BofA initiates coverage with 'buy' rating
Skye's obesity drug misses mid-stage trial main goal, shares tank (updated)
U.S. STOCKS ON THE MOVE-Energy stocks, Primerica, Micron Technology
U.S. STOCKS ON THE MOVE-Clean energy stocks, Energy stocks, McKesson
U.S. STOCKS ON THE MOVE-Boeing, gold miners, silver miners
Scholar Rock dips after US FDA declines to approve muscle weakness drug
US FDA declines to approve Scholar Rock's muscle weakness drug (updated)